Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713257 | 1.00 | MEN1 (0.46) | MEN1KMT2AAKR1C1TSHRMTNR1A | |
| SCHEMBL28483684 | 0.88 | MAPT (0.50) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL6701697 | 0.88 | MEN1 (0.51) | MEN1KMT2AMTNR1AMTNR1BALDH1A1 | |
| SCHEMBL1827687 | 0.82 | AKR1C1 (0.48) | MEN1KMT2AAKR1C1TSHRMTNR1A | |
| SCHEMBL6027509 | 0.80 | AKR1C1 (0.47) | MEN1KMT2AAKR1C1TSHRMTNR1A | |
| SCHEMBL2777335 | 0.79 | TSHR (0.50) | MEN1KMT2ATSHRALDH1A1MAPT | |
| SCHEMBL8588497 | 0.79 | TSHR (0.50) | MEN1KMT2ATSHRALDH1A1MAPT | |
| SCHEMBL342989 | 0.79 | TSHR (0.50) | MEN1KMT2ATSHRALDH1A1MAPT | |
| SCHEMBL23152622 | 0.78 | AKR1C1 (0.41) | MEN1KMT2AAKR1C1TSHRMTNR1A | |
| SCHEMBL11412872 | 0.78 | AKR1C1 (0.41) | MEN1KMT2AAKR1C1TSHRMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530030-A | CHLORINATED HYDROXYSTILBENES | KIORITZ CORPORATIN (JP) | 1996-06-25 | — | — | US | claimed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | claimed |
| JP-7118107-A | — | — | None | — | — | JP | disclosed |
| JP-5279223-A | — | — | None | — | — | JP | disclosed |
| CN-114096250-B | Therapies for erythropoiesis protoporphyria (EPP) and X-linked protoporphyria (XLP) | 匹兹堡大学 联邦高等教育系统 | 2025-01-14 | — | — | CN | disclosed |
| US-11786481-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11724998-B2 | PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| CN-114262252-A | Method for preparing olefin and alkane by catalyzing alkyne with quaternary ammonium salt | 云南民族大学 | 2022-04-01 | — | — | CN | disclosed |
| CN-114096250-A | Novel therapy for erythropoietic protoporphyrinopathy (EPP) and X-linked protoporphyrinopathy (XLP) | 匹兹堡大学联邦高等教育系统 | 2022-02-25 | — | — | CN | disclosed |
| WO-2021236764-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2021-11-25 | — | — | WO | disclosed |
| US-5530030-A | CHLORINATED HYDROXYSTILBENES | KIORITZ CORPORATIN (JP) | 1996-06-25 | — | — | US | disclosed |
| US-5530030-A | CHLORINATED HYDROXYSTILBENES | KIORITZ CORPORATIN (JP) | 1996-06-25 | — | — | US | disclosed |
| CN-1105973-A | Nematicides against pine wood nematodes | KIORITZ CORP (JP) | 1995-08-02 | — | — | CN | disclosed |
| JP-H07118107-A | NEMATOCIDE AGAINST PINE TREE NEMATODE | KIORITZ CORP | 1995-05-09 | — | — | JP | disclosed |
| WO-1994012621-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK (DK) | 1994-06-09 | — | — | WO | disclosed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | disclosed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | disclosed |
| JP-H05279223-A | AGENT FOR CONTROLLING BURSAPHELENEHUS LIGNICOLUS | KIORITZ CORP | 1993-10-26 | — | — | JP | disclosed |
| EP-0024567-A1 | 2-(4-Aminobutoxy)stilbenes and pharmaceutical compositions comprising these compounds | MITSUBISHI KASEI CORPORATION (JP) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | MEN1 4381/4885KMT2A 2925/4885AKR1C1 675/4885 |
| US-11786481-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | MEN1 4632/4885KMT2A 3278/4885AKR1C1 1878/4885 |
| US-11724998-B2 | PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention | NR1H2, NR1H4, NR1H3 | MEN1 4829/4885KMT2A 4703/4885AKR1C1 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.